Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.

Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT.

Dig Dis Sci. 2018 Oct;63(10):2815. doi: 10.1007/s10620-018-5249-3.

PMID:
30136047
2.

Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin.

Snydman DR, McDermott LA, Thorpe CM, Chang J, Wick J, Walk ST, Vickers RJ.

J Antimicrob Chemother. 2018 Aug 1;73(8):2078-2084. doi: 10.1093/jac/dky135.

PMID:
29718329
3.

A repeat offender: Recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation.

Gardiner BJ, Thorpe CM, Pinkham NV, McDermott LA, Walk ST, Snydman DR.

Anaerobe. 2018 Jun;51:68-72. doi: 10.1016/j.anaerobe.2018.04.007. Epub 2018 Apr 21.

PMID:
29709869
4.

Microbiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 Receptor.

Alexeev EE, Lanis JM, Kao DJ, Campbell EL, Kelly CJ, Battista KD, Gerich ME, Jenkins BR, Walk ST, Kominsky DJ, Colgan SP.

Am J Pathol. 2018 May;188(5):1183-1194. doi: 10.1016/j.ajpath.2018.01.011. Epub 2018 Feb 16.

PMID:
29454749
5.

Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.

Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT.

Dig Dis Sci. 2018 Apr;63(4):1016-1024. doi: 10.1007/s10620-018-4941-7. Epub 2018 Feb 8. Erratum in: Dig Dis Sci. 2018 Oct;63(10):2815.

PMID:
29417331
6.

SMV1, an extremely stable thermophilic virus platform for nanoparticle trafficking in the mammalian GI tract.

Uldahl KB, Walk ST, Olshefsky SC, Young MJ, Peng X.

J Appl Microbiol. 2017 Nov;123(5):1286-1297. doi: 10.1111/jam.13584. Epub 2017 Oct 10.

7.

Community Environmental Contamination of Toxigenic Clostridium difficile.

Alam MJ, Walk ST, Endres BT, Basseres E, Khaleduzzaman M, Amadio J, Musick WL, Christensen JL, Kuo J, Atmar RL, Garey KW.

Open Forum Infect Dis. 2017 Feb 10;4(1):ofx018. doi: 10.1093/ofid/ofx018. eCollection 2017 Winter.

8.

Healthy human gut phageome.

Manrique P, Bolduc B, Walk ST, van der Oost J, de Vos WM, Young MJ.

Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10400-5. doi: 10.1073/pnas.1601060113. Epub 2016 Aug 29.

9.

Serum 25-Hydroxyvitamin D Levels are not Associated with Adverse Outcomes in Clostridium Difficile Infection.

Micic D, Rao K, Trindade BC, Walk ST, Chenoweth E, Jain R, Trivedi I, Santhosh K, Young VB, Aronoff DM.

Infect Dis Rep. 2015 Sep 29;7(3):5979. doi: 10.4081/idr.2015.5979. eCollection 2015 Aug 11.

10.

Vaginal biogenic amines: biomarkers of bacterial vaginosis or precursors to vaginal dysbiosis?

Nelson TM, Borgogna JL, Brotman RM, Ravel J, Walk ST, Yeoman CJ.

Front Physiol. 2015 Sep 29;6:253. doi: 10.3389/fphys.2015.00253. eCollection 2015.

11.

The "Cryptic" Escherichia.

Walk ST.

EcoSal Plus. 2015;6(2). doi: 10.1128/ecosalplus.ESP-0002-2015. Review.

PMID:
26435255
12.

In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.

Aitken SL, Alam MJ, Khaleduzzaman M, Walk ST, Musick WL, Pham VP, Christensen JL, Atmar RL, Xie Y, Garey KW.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1318-23. doi: 10.1017/ice.2015.187. Epub 2015 Aug 20. Erratum in: Infect Control Hosp Epidemiol. 2016 Jan;37(1):124. Khaleduzzuman, Mohammed [corrected to Khaleduzzaman, Mohammed].

13.

Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality.

Rao K, Micic D, Natarajan M, Winters S, Kiel MJ, Walk ST, Santhosh K, Mogle JA, Galecki AT, LeBar W, Higgins PD, Young VB, Aronoff DM.

Clin Infect Dis. 2015 Jul 15;61(2):233-41. doi: 10.1093/cid/civ254. Epub 2015 Mar 31.

14.

Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology.

Martinson JN, Broadaway S, Lohman E, Johnson C, Alam MJ, Khaleduzzaman M, Garey KW, Schlackman J, Young VB, Santhosh K, Rao K, Lyons RH Jr, Walk ST.

J Clin Microbiol. 2015 Apr;53(4):1192-7. doi: 10.1128/JCM.03591-14. Epub 2015 Jan 28.

15.

Gender Differences in Non-Toxigenic Clostridium difficile Colonization and Risk of Subsequent C. difficile Infection.

Natarajan M, Rogers MA, Bundy J, Micic D, Walk ST, Santhosh K, Rao K, Winters S, Young VB, Aronoff DM.

Clin Res Infect Dis. 2015;2(2). pii: 1017. Epub 2015 Aug 3.

16.

Investigation of potentially pathogenic Clostridium difficile contamination in household environs.

Alam MJ, Anu A, Walk ST, Garey KW.

Anaerobe. 2014 Jun;27:31-3. doi: 10.1016/j.anaerobe.2014.03.002. Epub 2014 Mar 19.

PMID:
24657158
17.

The systemic inflammatory response to Clostridium difficile infection.

Rao K, Erb-Downward JR, Walk ST, Micic D, Falkowski N, Santhosh K, Mogle JA, Ring C, Young VB, Huffnagle GB, Aronoff DM.

PLoS One. 2014 Mar 18;9(3):e92578. doi: 10.1371/journal.pone.0092578. eCollection 2014.

18.

Emergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USA.

Jain R, Walk ST, Aronoff DM, Young VB, Newton DW, Chenoweth CE, Washer LL.

Infect Dis Rep. 2013 Mar 19;5(1):e5. doi: 10.4081/idr.2013.e5. eCollection 2013 Jan 22. Review.

19.

Candidate mediators of chondrocyte mechanotransduction via targeted and untargeted metabolomic measurements.

Jutila AA, Zignego DL, Hwang BK, Hilmer JK, Hamerly T, Minor CA, Walk ST, June RK.

Arch Biochem Biophys. 2014 Mar 1;545:116-23. doi: 10.1016/j.abb.2014.01.011. Epub 2014 Jan 16.

20.

Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping.

Behroozian AA, Chludzinski JP, Lo ES, Ewing SA, Waslawski S, Newton DW, Young VB, Aronoff DM, Walk ST.

Infect Control Hosp Epidemiol. 2013 Sep;34(9):961-966. doi: 10.1086/671728. Epub 2013 Jul 12.

Supplemental Content

Support Center